Post-traumatic stress disorder (PTSD) is associated with immune dysregulation. We have previously shown that severe stress exposure in a preclinical animal model of the disorder, stress-enhanced fear learning (SEFL), is associated with an increase in hippocampal interleukin-1b (IL-1b) and that blocking central IL-1 after the severe stress prevents the development of SEFL. Here, we tested whether blocking hippocampal IL-1 signaling is sufficient to prevent enhanced fear learning and identified the cellular source of stress-induced IL-1b in this region. Experiment 1 tested whether intra-dorsal hippocampal (DH) infusions of interleukin-1 receptor antagonist (IL-1RA, 1.25 mg per hemisphere) 24 and 48 h after stress exposure prevents the development of enhanced fear learning. Experiment 2 used triple fluorescence immunohistochemistry to examine hippocampal alterations in IL-1b, glial fibrillary acidic protein (GFAP), an astrocyte-specific marker, and ionized calcium binding adaptor molecule -1 (Iba-1), a microglial-specific marker, 48 h after exposure to the severe stressor of the SEFL paradigm. Intra-DH IL-1RA prevented SEFL and stress-induced IL-1b was primarily colocalized with astrocytes in the hippocampus. Further, hippocampal GFAP immunoreactivity was not altered, whereas hippocampal Iba-1 immunoreactivity was significantly attenuated following severe stress. These data suggest that hippocampal IL-1 signaling is critical to the development of SEFL and that astrocytes are a predominant source of stress-induced IL-1b.
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Introduction
Converging evidence from both human and animal studies has suggested that psychiatric disorders involving depression and anxiety, including post-traumatic stress disorder (PTSD), involve substantial immune system dysregulation (Koo and Duman, 2009; Silverman et al., 2007; Stepanichev et al., 2014; Gill et al., 2009; Jones et al., 2015) . Several published studies have reported that PTSD is associated with elevated peripheral cytokines, such as interleukin-1b (IL-b), tumor necrosis factor-a (TNF-a), and interleukin-6 (IL-6) (Gill et al., 2009; Gola et al., 2013; Passos et al., 2015; Guo et al., 2012; Wang and Young, 2016) . Cohen and colleagues have even suggested IL-1 as a potential biomarker for susceptibility to PTSD (Cohen et al., 2011) . Central IL-1 signaling is consistently shown to be upregulated by a variety of different stress protocols in rodents and to be critically involved in stress response mechanisms that drive behavioral outcomes (Goshen and Yirmiya, 2009; Avital et al., 2003) . For example, peripheral administration of IL-1b has been shown to lead to enhanced anxiety-like behavior in the elevated plus maze (EPM) (Swiergiel and Dunn, 2007) , and blocking IL-1 signaling centrally prevents stress-induced reductions in social interaction (Arakawa et al., 2009) . We recently published the finding that stress-enhanced fear learning (SEFL), a preclinical animal model of PTSD developed by Rau and colleagues (Rau et al., 2005) , requires central IL-1 signaling. Our data demonstrated that the severe stressor of the SEFL paradigm (15 foot shocks) induces an increase in IL-1b in the dorsal hippocampus (DH) 24-48 h after the stress. Furthermore, blocking IL-1 signaling in the brain through an intracerebroventricular infusion of IL-1 receptor antagonist (IL-1RA) prevents the development of enhanced fear learning (Jones et al., 2015) . Together these data suggest that central IL-1RA may be acting specifically in the hippocampus. Accordingly the first goal of the current study was to test whether hippocampal IL-1 signaling 24-48 h after severe stress is necessary for the expression of SEFL.
The second goal of the current study was to isolate and quantify colocalization of stress-induced IL-1b with cell-specific markers
